Posts Tagged: patents
IPWatchdog CON2020
This IPWatchdog® Conference will endeavor to address the issues facing innovators, creators and brand owners as they find it increasingly difficult to monetize their proprietary creations in …
Is Unified Patents a War Profiteer?
Is Unified a war profiteer? Of course, they are. But they are only one cog in the larger worldwide scheme of the most powerful multinational corporations whose …
The New U.S. Essential Patents Statement – Safeguarding the Integrity of the Patent System
In withdrawing the 2013 statement, the new 2019 guidance by the DOJ, NIST and the USPTO states the obvious, i.e. that there is no difference in the law …
What Happens at The Board Does Not Stay at The Board: How Patent Owners Can Leverage IPR Proceedings in Litigation
Inter Partes Review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) often occur in parallel to district court cases. Patent owners whose patent rights survive …
Innovators Rush to Solve Coronavirus Pandemic While Countries Contemplate Compulsory Licensing
Since China announced the first fatality caused by a virus about which little was known at the time, coronavirus and the disease it causes, COVID-19, has grown …
Antitrust and Patents: A Conversation with Makan Delrahim
Last week, as a part of the Virtual Patent Masters™ Program hosted by IPWatchdog, I had the opportunity to interview Makan Delrahim, who is Assistant Attorney General …
Facebook v. Windy City Settles It: The CAFC Does Not Care About the PTAB’s Opinions
The Supreme Court in SAS (SAS Institute Inc. v. Iancu) was quite clear that the Patent Trial and Appeal Board (PTAB or Board) has to follow the …
PTAB Designates Two Opinions Precedential on Discretion to Grant or Deny IPRs
Yesterday, the USPTO Patent Trial and Appeal Board designated two opinions as precedential. In one case, Advanced Bionics, LLC v. MED-EL Elektromedizinische Geräte GmbH, the Board …
Patent Filings Roundup: Medtronic Hit with Seven IPRs, Huawei Fields Multiple District Court Complaints
In the age of electronic filing, working from home and sheltering in place appears to have accelerated—or at least not slowed down significantly—district court and …
Sanofi Decision Presents Opportunities to Clear the Patent Thicket for Generic Pharmaceuticals
The U.S. Court of Appeals for the First Circuit has made brand companies think twice about creating patent thickets in the Orange Book by resuscitating an …
The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing
Yesterday, the U.S. Court of Appeals for the Federal Circuit denied rehearing en banc in Arthrex v. Smith & Nephew. Five of the 12 Federal Circuit judges wrote …
Death at a Funeral – or Birth? Why the German Court’s Decision on the UPC May Not be the End
n Friday, March 20, the German Constitutional Court (“Bundesverfassungsgericht”, “BverfG”) declared Germany’s approval legislation of the Agreement on a Unified Patent Court (UPC) unconstitutional. Those who have …
Federal Circuit Will Not Reconsider Arthrex Appointment Clause Ruling
The U.S. Court of Appeals for the Federal Circuit has denied rehearing en banc in Arthrex v. Smith & Nephew, a decision that made the Patent Trial …
Broadcom Asserts Patents Covering ‘Crucial Aspects’ of Netflix Content Delivery
On March 13, American semiconductor developer Broadcom Corporation filed a lawsuit in the Central District of California alleging claims of patent infringement against streaming media producer and provider …
Federal Circuit Finds District Court Did Not Err in Jury Instructions On ‘Ordinary Observer’ Standard
The U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a decision of the District Court for the Southern District of West Virginia finding that …
